Aventis Pharmaceuticals clinical trials
Acquired by Sanofi, Aug 20, 2004 · source ↗
The registry lists 2 studies whose lead sponsor is Aventis Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Dec 4, 2013.
Before and after it joined Sanofi
- First submitted before Aventis Pharmaceuticals became part of Sanofi
- 2
- First submitted after Aventis Pharmaceuticals became part of Sanofi
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Aventis Pharmaceuticals2 studies
Something wrong with this grouping? Tell us on the Sanofi page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Sanofi studies →
- Gene Therapy in Treating Patients With Recurrent Head and Neck CancerStatus unknownNCT00003257Phase 2
Sponsor listed in the registry: Aventis Pharmaceuticals · First submitted before Aventis Pharmaceuticals became part of Sanofi
- Paclitaxel or Docetaxel in Treating Women With Advanced Breast CancerCompletedNCT00002662Phase 3
Sponsor listed in the registry: Aventis Pharmaceuticals · First submitted before Aventis Pharmaceuticals became part of Sanofi